Bloomberg · Ike Swetlitz ·
Neuralink co-founder Max Hodak's Science Corp, which offers a retinal implant for age-related macular degeneration, raised $400M at a $3.5B valuation
Science Corp, the company behind a retinal chip that restores some vision to people with an age-related form of blindness, is valued at $3.5 billion after a recent fundraising round.
Lead Source
How this story grew
Coverage · 0
Discussion · 0
Nov 17Nov 18
More
Discussion
Related stories
Business Insider: Former OpenAI Chief Product Officer Kevin Weil is aiming to raise $150M for a new AI science startup, seeking a valuation of at least $750M